Missouri sues FDA over generic mifepristone approval
Missouri Attorney General Catherine Hanaway announced Thursday a lawsuit challenging the FDA’s Sept. 30 approval of a generic mifepristone by Evita Solutions, arguing mail-order distribution lacks required medical safeguards. Missouri, joined by Kansas and Idaho, asks the court to block the new approval, reinstate pre‑2016 in‑person evaluation requirements, and halt nationwide mailing of abortion pills.
Abortion and FDA
State Attorneys General
📌 Key Facts
- Filing targets FDA’s Sept. 30 approval of Evita Solutions’ generic mifepristone
- Missouri leads the suit; Kansas and Idaho have joined the challenge
- Requested relief: block the approval, restore pre‑2016 in‑person safeguards, and stop mailing abortion pills nationwide